Advances in the Treatment of Nasopharyngeal Cancer

2,690
Total downloads
13k
Total views and downloads

Articles

ORIGINAL RESEARCH

Accepted on 23 Oct 2025

Efficacy and Safety of Apatinib or Anlotinib Combined with PD-1 Inhibitors-Based Therapy as Subsequent-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Real-World Retrospective Study

Jingjing Gao
Jingshu Xu
Yiyue He
Dan Zong
Tong Jin
Xia He

doi 10.3389/fonc.2025.1624286

ORIGINAL RESEARCH

Published on 18 Jul 2025

Random forest model analysis of influencing factors of chemotherapy-induced peripheral neuropathy in patients with nasopharyngeal carcinoma: a cross-sectional survey study

Yanxin Zhang
Xiaojun Huang
Guirong Yang
Wei Li
Limin Liang
Lina Wei
Jiamei Lu

doi 10.3389/fonc.2025.1548742

939 views

SYSTEMATIC REVIEW

Published on 09 Jun 2025

Efficacy and safety of first-line treatments for recurrent or metastatic nasopharyngeal carcinoma: a systematic review and network meta-analysis

Tongze Cai
Caiyue Lin
Qiongqian Li
Juanmei Mo
Jinghui Zheng
Jianlong Zhou

doi 10.3389/fimmu.2025.1485609

2,728 views
1 citation

ORIGINAL RESEARCH

Published on 23 May 2025

tRF-1:28-Val-CAC-2 promotes the development of nasopharyngeal cancer by targeting EPHB2

Hui Li
Xiaomin Wang
Anchi Sun
Weiwei Liu
Rongrong Lv
Mingjie Zhang
Zhiwei Xing
Shiyin Ma
Yehai Liu
Kai Zhang

doi 10.3389/fonc.2025.1564601

1,453 views

ORIGINAL RESEARCH

Published on 14 May 2025

Prediction of induction chemotherapy efficacy in patients with locally advanced nasopharyngeal carcinoma using habitat subregions derived from multi-modal MRI radiomics

Mulan Pan
Lu Lu
Xingyu Mu
Guanqiao Jin

doi 10.3389/fonc.2025.1539574

1,549 views

CASE REPORT

Published on 03 Mar 2025

Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology

Fabiano Flauto
Rosa Maria Di Crescenzo
Vincenzo Damiano

doi 10.3389/fonc.2025.1523481

2,158 views
2 citations

ORIGINAL RESEARCH

Published on 31 Jan 2025

Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: a preliminary study by using contrast-enhanced ultrasound

Zhendong Yang
Huimin Xiao
Xigui Li
Zhuxin Wei
Min Kang
Rensheng Wang
Jianyuan Huang

doi 10.3389/fonc.2025.1521762

1,018 views
1 citation

Share on

Frontiers in Oncology

Head and Neck Cancer

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

13kTopic views
9,254Article views
2,690Article downloads

View impact

Articles

Efficacy and Safety of Apatinib or Anlotinib Combined with PD-1 Inhibitors-Based Therapy as Subsequent-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Real-World Retrospective Study

Random forest model analysis of influencing factors of chemotherapy-induced peripheral neuropathy in patients with nasopharyngeal carcinoma: a cross-sectional survey study

Efficacy and safety of first-line treatments for recurrent or metastatic nasopharyngeal carcinoma: a systematic review and network meta-analysis

tRF-1:28-Val-CAC-2 promotes the development of nasopharyngeal cancer by targeting EPHB2

Prediction of induction chemotherapy efficacy in patients with locally advanced nasopharyngeal carcinoma using habitat subregions derived from multi-modal MRI radiomics

Case Report: Unresectable recurrent nasopharyngeal cancer treated with immuno oncology

Antiangiogenic therapy with recombinant human endostatin may improve blood perfusion of cervical node with necrosis in nasopharyngeal carcinoma patients: a preliminary study by using contrast-enhanced ultrasound

Frontiers in Oncology

Head and Neck Cancer